SEARCH

SEARCH BY CITATION

References

  • 1
    Klinman DM, Steinberg AD: Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 165: 17551760, 1987
  • 2
    Block SR, Gibbs CB, Stevens MB, Shulman LE: Delayed hypersensitivity in systemic lupus erythematosus. Ann Rheum Dis 27: 311318, 1968
  • 3
    Alcocer-Varela J, Laffon A, Alarcon-Segovia D: Defective monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus. Clin Exp Immunol 54: 125132, 1983
  • 4
    Alcocer-Varela J, Alarcon-Segovia D: Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 69: 13881392, 1982
  • 5
    Linker-Israeli M, Bakke AC, Kitridou RC, Gendler S, Gillis S, Horwitz D: Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol 130: 26512655, 1983
  • 6
    Morimoto C, Steinberg AD, Letvin NL, Hagan M, Takeuchi T, Daley J, Levine H, Schlossman SF: A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest 79: 762768, 1987
  • 7
    Via GS, Tsokos GC, Bermas B, Clerici M, Shearer GM: T cell-antigen-presenting cell interactions in human systemic lupus erythematosus: evidence for heterogeneous expression of multiple defects. J Immunol 151: 39143922, 1993
  • 8
    Rousset F, Garcia E, Defrance T, Peronne C, Hsu DH, Kastelein R, Moore KW, Banchereau J: Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A 89: 18901893, 1992
  • 9
    Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Morel-Fourrier B, Brouet JC, Alarcon-Segovia D, Galanaud P, Emilie D: Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181: 839844, 1995
  • 10
    De Waal Malefyt R, Yssel H, de Vries JE: Direct effect of IL-10 on subsets of human CD4+ T cells clones and resting T cells: specific inhibition of IL-2 production and proliferation. J Immunol 150: 47544765, 1993
  • 11
    Enk AH, Angeloni VL, Udey MC, Katz SI: Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. J Immunol 151: 23902398, 1993
  • 12
    Howard M, O'Garra A: Biological properties of interleukin 10. Immunol Today 6: 198200, 1992
  • 13
    Llorente L, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Maillot MC, Durand-Gasselin I, Morel-Fourrier B, Galanaud P, Emilie D: Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 4: 421430, 1993
  • 14
    Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier B Morel, Galanaud P, Emilie D: In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis. Sjögren's syndrome, and systemic lupus erythematosus: a potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 37: 16471655, 1994
  • 15
    Hagiwara E, Gourley MF, Lee S, Klinman DM: Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-γ-secreting cells in the peripheral blood. Arthritis Rheum 39: 379385, 1996
  • 16
    Houssiau FA, Lefebvre C, van den Berghe M, Lambert M, Devogelaer J-P, Renauld J-J: Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 4: 393395, 1995
  • 17
    Al-Janadi M, Al-Dalaan A, Al-Balla S, Al-Humaidi M, Raziuddin S: Interleukin-10 secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B-cell antibody synthesis. J Clin Immunol 16: 198207, 1996
  • 18
    Miles S, Isenberg D: A review of serological abnormalities in relatives of SLE patients. Lupus 2: 145150, 1993
  • 19
    Sakane T, Murakawa Y, Suzuki N, Ueda Y, Tsuchida T, Takada S, Yamauchi Y, Tsunematsu T: Familial occurrence of impaired interleukin-2 activity and increased peripheral blood B cells actively secreting immunoglobulins in systemic lupus erythematosus. Am J Med 86: 385390, 1989
  • 20
    Clark J, Bourne T, Salaman MR, Seifert MH, Isenberg DA: B lymphocyte hyperactivity in families of patients with systemic lupus erythematosus. J Autoimmun 9: 5965, 1996
  • 21
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 12711277, 1982
  • 22
    O'Garra A, Chang R, Go N, Hastings R, Haughton G, Howard M: Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 22: 711717, 1992
  • 23
    Perez L, Orte J, Brieva JA: Terminal differentiation of spontaneous rheumatoid factor-secreting B cells from rheumatoid arthritis patients depends on endogenous interleukin-10. Arthritis Rheum 38: 17711776, 1995
  • 24
    Kotzin BL: Systemic lupus erythematosus. Cell 85: 303306, 1996
  • 25
    Theofilopoulos AN: The basis of autoimmunity. Part II. Genetic disposition. Immunol Today 16: 150159, 1995
  • 26
    Granados J, Vargas-Alarcón G, Andrade F, Melin-Aldana H, Alcocer-Varela J, Alarcón-Segovia D: The role of HLA-DR alleles and complotypes through the ethnic barrier in systemic lupus erythematosus in Mexicans. Lupus 5: 184189, 1996
  • 27
    Huang D-F, Siminovitch KA, Liu X-Y, Olee T, Olsen NJ, Berry C, Carson DA, Chen PP: Population and family studies of three disease-related polymorphic genes in systemic lupus erythematosus. J Clin Invest 95: 17661772, 1995
  • 28
    Kumar A, Martinez-Tarquino C, Maria-Forte A, Kumar P, Alarcon-Segovia D, Granados J, Pandey JP, Buxbaum J, Schur PH: Immunoglobulin heavy chain constant-region gene polymorphism in systemic lupus erythematosus. Arthritis Rheum 34: 15531556, 1991
  • 29
    Tebib JG, Alcocer-Varela J, Alarcon-Segovia D, Schur P: Association between a T cell receptor restriction fragment length polymorphism (RFLP) and systemic lupus erythematosus. J Clin Invest 86: 19611967, 1990
  • 30
    Tountas NA, Cominelli F: Identification and initial characterization of two polymorphisms in the human interleukin-10 promoter (abstract). Eur Cytokine Netw 7: 578, 1996
  • 31
    Eskdale J, Wordsworth P, Field M, Gallagher G: Distribution of IL-10 promoter microsatellite alleles in systemic lupus erythematosus and rheumatoid arthritis (abstract). Arthritis Rheum 39 (Suppl 9): S127, 1996
  • 32
    Kono DH, Burlingame RW, Owens DG, Kuramochi A, Balderas RS, Balomenos D, Theofilopoulos AN: Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci U S A 91: 1016810172, 1994
  • 33
    Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M: Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179: 305310, 1994
  • 34
    Ishida H, Hastings R, Kearney J, Howard M: Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med 175: 12131220, 1992
  • 35
    Nisitani S, Tsubata T, Murakami M, Honjo T: Administration of interleukin-5 or -10 activates peritoneal B-1 cells and induces autoimmune hemolytic anemia in anti-erythrocyte autoantibody-transgenic mice. Eur J Immunol 25: 30473052, 1995